Evaluation of early rheumatoid arthritis disease activity and outcome (Q41410246)

30 September 2017

1 reference

title

Evaluation of early rheumatoid arthritis disease activity and outcome (English)

1 reference

30 September 2017

1 reference

van Gestel AM

1

1 reference

PubMed ID

9088524

30 September 2017

van Riel PL

series ordinal

2

1 reference

30 September 2017

1 February 1997

1 reference

Bailliere's clinical rheumatology

30 September 2017

1 reference

30 September 2017

11

1 reference

30 September 2017

1

1 reference

30 September 2017

49-63

1 reference

Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugs

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Radiographic changes in early rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Which outcome measures should be used in rheumatoid arthritis clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Toward an understanding of patient outcome measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

The measurement of clinical pain intensity: a comparison of six methods

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Acute phase proteins in the monitoring of inflammatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

The assessment of disease activity in rheumatoid arthritis using a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Measuring health status in arthritis. The arthritis impact measurement scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

Comparison of the validity and reliability of self-reported articular indices

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

JOINTS COUNT: A REVIEW OF OLD AND NEW ARTICULAR INDICES OF JOINT INFLAMMATION

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980032-5

7 January 2021

10.1016/S0950-3579(97)80032-5

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9088524